VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $130,000 | +4.0% | 20,766 | -0.5% | 0.00% | – |
Q2 2021 | $125,000 | -34.9% | 20,866 | -31.2% | 0.00% | – |
Q1 2021 | $192,000 | +73.0% | 30,308 | +54.4% | 0.00% | – |
Q4 2020 | $111,000 | -6.7% | 19,632 | -3.8% | 0.00% | – |
Q3 2020 | $119,000 | -16.2% | 20,414 | +3.5% | 0.00% | – |
Q2 2020 | $142,000 | +43.4% | 19,725 | -5.5% | 0.00% | – |
Q1 2020 | $99,000 | -65.9% | 20,867 | -40.1% | 0.00% | -100.0% |
Q4 2019 | $290,000 | +79.0% | 34,854 | +59.4% | 0.00% | – |
Q3 2019 | $162,000 | -14.3% | 21,863 | -1.5% | 0.00% | – |
Q2 2019 | $189,000 | -18.9% | 22,193 | -2.7% | 0.00% | -100.0% |
Q1 2019 | $233,000 | +32.4% | 22,816 | +2.2% | 0.00% | 0.0% |
Q4 2018 | $176,000 | -40.9% | 22,314 | +30.7% | 0.00% | 0.0% |
Q3 2018 | $298,000 | +15.5% | 17,077 | -36.9% | 0.00% | 0.0% |
Q2 2018 | $258,000 | – | 27,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |